One year on – state of play in the EU on oncology biosimilars

Date 21 October 2018
Event ESMO 2018 Congress
Session ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?
Topics Bioethics, Legal, and Economic Issues
Therapy
Presenter Murray Aitken
Authors M. Aitken
  • Quintilesims Institute, IMS Health, NJ 07054 - Parsippany/US